Resected Hepatocellular Carcinoma in a Patient with Crohn's Disease on Azathioprine.

about

Resected Hepatocellular Carcinoma in a Patient with Crohn's Disease on Azathioprine.

Item

http://www.wikidata.org/entity/Q42463320

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Resected Hepatocellular Carcinoma in a Patient with Crohn's Disease on Azathioprine.

@en

Resected Hepatocellular Carcinoma in a Patient with Crohn's Disease on Azathioprine.

@nl

type

Item

label

Resected Hepatocellular Carcinoma in a Patient with Crohn's Disease on Azathioprine.

@en

Resected Hepatocellular Carcinoma in a Patient with Crohn's Disease on Azathioprine.

@nl

prefLabel

Resected Hepatocellular Carcinoma in a Patient with Crohn's Disease on Azathioprine.

@en

Resected Hepatocellular Carcinoma in a Patient with Crohn's Disease on Azathioprine.

@nl

P1476

Resected Hepatocellular Carcinoma in a Patient with Crohn's Disease on Azathioprine.

@en

P2093

Andrew Szilagyi

http://www.w3.org/2001/XMLSchema#string

Gillian Spiegle

http://www.w3.org/2001/XMLSchema#string

Kyle Joshua Fortinsky

http://www.w3.org/2001/XMLSchema#string

Nir Hilzenrat

http://www.w3.org/2001/XMLSchema#string

Valérie Heron

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease.

Iron, hemochromatosis, and hepatocellular carcinoma.

Metastatic hepatocellular carcinoma in a patient with Crohn's disease treated with azathioprine and infliximab: a case report and literature review

Spontaneous regression of hepatocellular carcinoma is most often associated with tumour hypoxia or a systemic inflammatory response.

Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver.

Spontaneous regression of hepatocellular carcinoma: a systematic review.

Hepatocellular carcinoma occurring in a Crohn's disease patient.

Hepatosplenic T-cell lymphoma, immunosuppressive agents and biologicals: what are the risks?

Efforts to explain spontaneous regression of cancer.

Risk of cancer in inflammatory bowel disease treated with azathioprine: a UK population-based case-control study.

P304

50-56

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1159/000444012

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27403102

http://www.w3.org/2001/XMLSchema#string

P932

4929375

http://www.w3.org/2001/XMLSchema#string